SANGAMO THERAPEUTICS, INC. Deferred Foreign Income Tax Expense (Benefit)
SANGAMO THERAPEUTICS, INC. (SGMOQ) reported Deferred Foreign Income Tax Expense (Benefit) of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2026-03-30
- SANGAMO THERAPEUTICS, INC. deferred foreign income tax expense (benefit) for fiscal 2025 was $0.00.
- SANGAMO THERAPEUTICS, INC. deferred foreign income tax expense (benefit) for fiscal 2024 was $0.00.
- SANGAMO THERAPEUTICS, INC. deferred foreign income tax expense (benefit) for fiscal 2023 was -$5.26M.
- SANGAMO THERAPEUTICS, INC. deferred foreign income tax expense (benefit) for fiscal 2022 was -$71.00K.
| Period end | Deferred Foreign Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-30 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-30 |
| 2023-12-31 | -$5.26M 10-K · filed 2025-03-17 |
| 2022-12-31 | -$71.00K 10-K · filed 2024-03-13 |
| 2021-12-31 | -$580.00K 10-K · filed 2024-03-13 |
| 2020-12-31 | -$474.00K 10-K · filed 2023-02-23 |
| 2019-12-31 | $0.00 10-K · filed 2022-02-24 |
| 2018-12-31 | $0.00 10-K · filed 2021-02-24 |
| 2017-12-31 | $0.00 10-K · filed 2020-02-28 |